Lukas de Haas

1PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Apr 16, 2022
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.

Camille Le Gall, Anna Cammarata, Lukas de Haas

Pageof 1

Frequent Collaborators

1 joint publications

Camille Le Gall

1 joint publications

Anna Cammarata

1 joint publications

Iván Ramos-Tomillero

1 joint publications

Jorge Cuenca-Escalona